Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

Breast Cancer Research and Treatment

Volumn 130, Issue 2, 2011, Pages 449-455

  Raimondi, Cristina ^a   Gradilone, Angela ^b   Naso, Giuseppe ^a   Vincenzi, Bruno ^c   Petracca, Arianna ^b   Nicolazzo, Chiara ^b   Palazzo, Antonella ^a   Saltarelli, Rosa ^d   Spremberg, Franco ^d   Cortesi, Enrico ^a   Gazzaniga, Paola ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d S Giovanni Evangelista Hospital   (Italy)

Author keywords

Cancer stem cells; Circulating tumor cells; Cytokeratins; Epithelial mesenchymal transition

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN RECEPTOR ALPHA; FIBRONECTIN; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CELL FUNCTION; CELL ISOLATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEMNESS;

BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA; FEMALE; FIBRONECTINS; HUMANS; ISOENZYMES; KI-67 ANTIGEN; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; RECEPTOR, ERBB-2; RETINAL DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 82955187028     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1373-x     Document Type: Article

References (22)

1. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791 (Pubitemid 39095313)
2. Mostert B, Sleijfer S, Foekens J, Gratama J (2009) Circulating tumor cells (CTCs): detection methods and their clinical rele-vance in breast cancer. Cancer Treat Rev 35:463-474
3. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329-340 (Pubitemid 351596394)
4. Amadori A, Rossi E, Zamarchi R, Carli P, Pastorelli D, Birillo A (2009) Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions. Oncology 76:375-386
5. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12:4218-4224
6. Gage T, Fan SL (2010) What goes around, comes around: a review of circulating tumor cells. MLO Med Lab Obs 32:34-36
7. Maheswaran S, Haber DA (2010) Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 20:96-99
8. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:293-299
9. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia (in press)
10. Ouyang G, Wang Z, Fang X, Liu J, Yang CJ (2010) Molecular signaling of the epithelial to mesenchymal transition in generat-ing and maintaining cancer stem cells. Cell Mol Life Sci (in press)
11. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ (2007) Progress and promise: highlights of the interna-tional expert consensus on the primary therapy of early breast cancer 2007.10th St. Gallen conference. Ann Oncol 18(7):1133-1144 (Pubitemid 47244357)
12. Gazzaniga P, Naso G, Gradilone A, Cortesi E, Gandini O, Gianni W, Fabbri MA, Vincenzi B, di Silverio F, Frati L, Aglianò AM, Cristofanilli M (2010) Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epi-thelial tumors. Int J Cancer 126(10):2437-2447
13. Mego M, Mani C, Li C, Andreoupolou E, Tin S, Jackson S, Cohen E, Gao H, Cristofanilli M, Reuben J (2009) Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in breast cancer: describing the heterogeneity of microscopic disease. Cancer Research 69 (Meeting Abstract Supplement), 3011. doi:10.1158/0008-5472.SABCS-09-3011
14. Franzen B, Linder S, Alaiya AA, Eriksson E, Uruy K, Hirano T, Okuzawa K, Auer G (1996) Analysis ofpolypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br J Cancer 74:1632-1638 (Pubitemid 26386093)
15. Weckermann D, Muller P, Wawroschek F, Harzmann R, Riet-hmüller G, Schlimok G (2001) Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value. J Urol 166:699-703
16. Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K (2003) Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63:5679-5684 (Pubitemid 37187461)
17. Woelfle U, Sauter G, Santjer S, Braakenhoff RH, Pantel K (2004) Downregulated expression of cytokeratin 18 promotes progres-sion of human breast cancer. Clin Cancer Res 10:2670-2674 (Pubitemid 38509140)
18. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K (2005) Changes in cytoskeletal protein composition indicative of an epithelial-mes-enchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11:8006-8014 (Pubitemid 41698741)
19. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschins-kaya S, Köchli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G, Gastl G (2004) High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 86:207-213 (Pubitemid 39070963)
20. Raimondi C, Gianni W, Cortesi E, Gazzaniga P (2010) Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Curr Cancer Drug Targets 10:496-508
21. Monteiro J, Fodde R (2010) Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer 46: 1198-1203
22. Munz M, Baeuerle PA, Gires O (2009) The emerging role of Ep CAM in cancer and stem cell signaling. Cancer Res 69:5627-5629